AI-First Business Models Seek to Reshape Drug Discovery
The pharmaceutical industry has long struggled with sky-high costs, lengthy development timelines, and an overwhelming failure rate in drug discovery. Now, a wave of AI-driven startups is aiming to change that. By adopting an AI-first business model, these companies are using computational power to accelerate the identification of life-saving therapeutics....